Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Conditions We Treat with Biologics and Immunotherapy: Brain Tumors
Types of Brain Tumors We Treat with Cancer Biologics and Immunotherapy
Cancer biologics and immunotherapy drugs are some of the most advanced treatments for many types of brain tumors. These medications are designed to target specific genes, proteins and other substances that control growth in different types of cancer cells.
At Stanford, we offer genetic testing, when appropriate, to detect the genes, proteins and other substances in your tumor that we may be able to target with these therapies. This testing helps us decide on the specific medications that can be the most effective against your specific tumor.
The U.S. Food and Drug Administration has approved some targeted therapies to treat cancerous brain tumors. Many others are still in research and development in clinical trials. We offer patients access to the latest clinical trials for the latest immunotherapy treatments for many types of brain tumors, including:
Metastatic Brain Tumors
These cancerous (malignant) tumors begin in another part of the body and spread (metastasizes) to the brain. Read more about metastatic brain tumors.
Primary Brain Tumors
Less common than metastatic brain tumors, primary brain tumors begin growing in the brain. We use cancer biologics and immunotherapy to treat malignant primary tumors. Learn more about our expert care for primary brain tumors.
Spinal tumors grow in the spinal cord, spinal column (backbone) or nerve roots stemming from the spinal cord. They can be noncancerous (benign) or malignant, and primary or metastatic. Find out about care for spinal tumors at the Neurosurgical Spinal Tumors Clinic.